Filtering by
- All Subjects: Peatlands
- All Subjects: Obesity--Surgery.
Tropical peatlands play a critical role in global carbon storage and greenhouse gas flux, yet the role of microbial communities in these ecosystems remains poorly understood. Methane-oxidizing bacteria (MOB) are considered an efficient biological filter for methane and can mitigate its release into the atmosphere, facilitating an ecosystem’s capacity to become a net sink. Prokaryotic gene amplicon surveys targeting a unique biomarker instead of a universal one (i.e., 16S rRNA) can reveal a more comprehensive analysis of microbial communities with ecological functions (i.e., methanotrophy). The alpha subunit of particulate methane monooxygenase (pmoA) is commonly targeted as a phylogenetic biomarker for both aerobic and anaerobic MOB. Here, we tested three different primer sets and investigated their ability to assess methanotrophic diversity across three biogeochemically distinct tropical peatland sites in the Pastaza-Marañón foreland basin (PMFB) in western Amazonia. The results showed that sequencing using 16S rRNA and pmoA genes revealed differences in MOB taxonomic identification in 21 tropical peat soils. Beta diversity analysis of pmoA genes suggests that site location is not the main driver of differences in MOB community makeup. This work offers insight into the strengths and weaknesses of targeted gene amplicon surveys using 16S and pmoA from tropical peat soils as a case study.
Roux-en-Y gastric bypass (RYGB) rearranges the gastrointestinal tract and reduces gastric acid secretions. Therefore, pH could be one of the factors that change microbiome after RYGB. Using mixed-cultures and co-cultures of species enriched after RYGB, I showed that as small as 0.5 units higher gut pH can aid in the survival of acid-sensitive microorganisms after RYGB and alter gut microbiome function towards the production of weight loss-associated metabolites. By comparing microbiome after two different bariatric surgeries, RYGB and laparoscopic adjustable gastric banding (LAGB), I revealed that gut microbiome structure and metabolism after RYGB are remarkably different than LAGB, and LAGB change microbiome minimally. Given the distinct RYGB alterations to the microbiome, I examined the contribution of the microbiome to weight loss. Analyses revealed that Fusobacterium might lessen the success of RYGB by producing putrescine, which may enhance weight-gain and could serve as biomarker for unsuccessful RYGB.
Finally, I showed that RYGB alters the luminal and the mucosal microbiome. Changes in gut microbial metabolic products occur in the short-term and persist over the long-term. Overall, the work in this dissertation provides insight into how the gut microbiome structure and function is altered after bariatric surgery, and how these changes potentially affect the host metabolism. These findings will be helpful in subsequent development of microbiome-based therapeutics to treat obesity.